These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12629203)

  • 1. Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys.
    Grondin R; Cass WA; Zhang Z; Stanford JA; Gash DM; Gerhardt GA
    J Neurosci; 2003 Mar; 23(5):1974-80. PubMed ID: 12629203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys.
    Maswood N; Grondin R; Zhang Z; Stanford JA; Surgener SP; Gash DM; Gerhardt GA
    Neurobiol Aging; 2002; 23(5):881-9. PubMed ID: 12392792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys.
    Gash DM; Zhang Z; Cass WA; Ovadia A; Simmerman L; Martin D; Russell D; Collins F; Hoffer BJ; Gerhardt GA
    J Comp Neurol; 1995 Dec; 363(3):345-58. PubMed ID: 8847404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraputamenal infusion of GDNF in aged rhesus monkeys: distribution and dopaminergic effects.
    Ai Y; Markesbery W; Zhang Z; Grondin R; Elseberry D; Gerhardt GA; Gash DM
    J Comp Neurol; 2003 Jun; 461(2):250-61. PubMed ID: 12724841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats.
    Hebert MA; Gerhardt GA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):760-8. PubMed ID: 9262339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis.
    Hebert MA; Van Horne CG; Hoffer BJ; Gerhardt GA
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1181-90. PubMed ID: 8968339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats.
    Bowenkamp KE; Lapchak PA; Hoffer BJ; Miller PJ; Bickford PC
    Exp Neurol; 1997 May; 145(1):104-17. PubMed ID: 9184114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys.
    Grondin R; Zhang Z; Yi A; Cass WA; Maswood N; Andersen AH; Elsberry DD; Klein MC; Gerhardt GA; Gash DM
    Brain; 2002 Oct; 125(Pt 10):2191-201. PubMed ID: 12244077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
    Hoffman AF; van Horne CG; Eken S; Hoffer BJ; Gerhardt GA
    Exp Neurol; 1997 Sep; 147(1):130-41. PubMed ID: 9294410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys.
    Johnston LC; Eberling J; Pivirotto P; Hadaczek P; Federoff HJ; Forsayeth J; Bankiewicz KS
    Hum Gene Ther; 2009 May; 20(5):497-510. PubMed ID: 19203243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
    Kirik D; Rosenblad C; Björklund A
    Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys.
    Gerhardt GA; Cass WA; Yi A; Zhang Z; Gash DM
    J Neurochem; 2002 Jan; 80(1):168-77. PubMed ID: 11796755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection.
    Lapchak PA; Jiao S; Collins F; Miller PJ
    Brain Res; 1997 Jan; 747(1):92-102. PubMed ID: 9042532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys.
    Oiwa Y; Nakai K; Itakura T
    Neurol Med Chir (Tokyo); 2006 Jun; 46(6):267-75; discussion 275-6. PubMed ID: 16794346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.
    Kordower JH; Emborg ME; Bloch J; Ma SY; Chu Y; Leventhal L; McBride J; Chen EY; Palfi S; Roitberg BZ; Brown WD; Holden JE; Pyzalski R; Taylor MD; Carvey P; Ling Z; Trono D; Hantraye P; Déglon N; Aebischer P
    Science; 2000 Oct; 290(5492):767-73. PubMed ID: 11052933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease.
    Grondin R; Gash DM
    J Neurol; 1998 Nov; 245(11 Suppl 3):P35-42. PubMed ID: 9808338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor concentration dependently improves disability and motor activity in MPTP-treated common marmosets.
    Costa S; Iravani MM; Pearce RK; Jenner P
    Eur J Pharmacol; 2001 Jan; 412(1):45-50. PubMed ID: 11166735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease.
    Kirik D; Georgievska B; Rosenblad C; Björklund A
    Eur J Neurosci; 2001 Apr; 13(8):1589-99. PubMed ID: 11328352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.